ALKERMES | ALKS - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q3 Sep/2026 0.09 0.01 0.49 Nov/03
FY2026Q2 Jun/2026 -0.02 0.52 Jul/28
FY2026Q1 Mar/2026 -0.40 -0.4 0.13 May/05
FY2025Q4 Dec/2025 0.29 0.42 1.05 Feb/25
FY2025Q3 Sep/2025 0.49 0.4 0.73 Oct/28




Eps Cambiamento Data
AbbVie USD 3.82 0.17 2026-09
Acadia Pharmaceuticals USD 0.31 0.13 2026-09
ALKERMES USD 0.09 0.09 2026-09
Amgen USD 6.45 0.16 2026-09
Biogen USD 2.62 0.98 2026-09
BioMarin Pharmaceutical USD 0.23 0.97 2026-09
Bristol-Myers Squibb USD 1.35 0.69 2026-09
Coherus Biosciences USD -0.43 0.06 2025-12
Eli Lilly USD 7.48 0.9 2026-09
Gilead Sciences USD 2.55 9.3 2026-09
Heron Therapeutics USD -0.02 0.02 2025-12
Ionis Pharmaceuticals USD 0.66 1.35 2026-09
J&J USD 2.7 0.2 2026-09
Malin Corporation EUR -0.06 0.1 2023-12
Merck USD 2.49 2.62 2026-09
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -1.78 0.43 2026-03
Neurocrine Biosciences USD 3.29 0.44 2026-09
Otsuka Holdings JPY 202.96 19.8 2026-09
Ovoca Bio EUR 0 0.06 2025-12
Pfizer USD 0.87 0.1 2026-09
Regeneron Pharmaceuticals USD 20.07 5.78 2026-09
Vertex Pharmaceuticals USD 4.76 0.03 2026-09